Dietary phytoestrogen intake and ovarian cancer risk: a prospective study in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort

Yizuo Song,Huijun Huang,Mingmin Jin,Binwei Cheng,Shanshan Wang,Xinjun Yang,Xiaoli Hu
DOI: https://doi.org/10.1093/carcin/bgae015
2024-02-22
Carcinogenesis
Abstract:Estrogen plays crucial roles in ovarian tumorigenesis. Phytoestrogens (PEs) are a type of daily dietary nutrients for humans and possess a mild estrogenic characteristic. This study aimed to assess the correlation of the consumption of dietary PEs with ovarian cancer risk using data in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Participants were enrolled in PLCO from 1993 to 2001. Hazard ratios (HRs) and 95% confidence intervals (CIs) were utilized to determine the association between the intake of PEs and ovarian cancer occurrence, which were calculated by the Cox proportional hazards regression analysis. Totally, 24,875 participants were identified upon completion of the initial dietary questionnaire (DQX). Furthermore, the analysis also included a total of 45,472 women who filled out the diet history questionnaire (DHQ). Overall, after adjustment for confounders, the dietary intake of total PEs was significantly associated with the risk of ovarian cancer in the DHQ group (HR Q4vsQ1 = 0.69, 95% CI: 0.50-0.95; P for trend = 0.066). Especially, individuals who consumed the highest quartile of isoflavones were found to have a decreased risk of ovarian cancer in the DHQ group (HR Q4vsQ1 = 0.68, 95% CI: 0.50-0.94; P for trend = 0.032). However, no such significant associations were observed for the DQX group. In summary, this study suggests that increased dietary intake of total PEs especially isoflavones was linked with a lower risk for developing ovarian cancer. More researches are necessary to validate the findings and explore the potential mechanisms.
oncology
What problem does this paper attempt to address?
The problem this paper attempts to address is the evaluation of the relationship between dietary phytoestrogen (PE) intake and the risk of ovarian cancer. Specifically, the researchers aim to investigate whether dietary phytoestrogen intake affects the risk of developing ovarian cancer by analyzing data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. ### Research Background - **Ovarian Cancer**: In 2020, approximately 207,252 women worldwide died from ovarian cancer, making it one of the most lethal gynecological cancers. Due to the lack of effective early screening methods, ovarian cancer is usually detected at a late stage, leading to poor prognosis. - **Estrogen**: 17β-estradiol (also known as estrogen/E2) is the primary estrogen synthesized and secreted by the ovaries. Women typically enter menopause in their 40s or 50s, experiencing various postmenopausal symptoms such as osteoporosis and hot flashes due to the permanent loss of ovarian hormone synthesis function. Women who are exposed to estrogen for a long period are more likely to develop ovarian cancer. - **Phytoestrogens**: Phytoestrogens are a class of compounds extracted from soybeans, structurally similar to mammalian 17β-estradiol, and possess mild estrogenic activity. Soybeans and their derivatives are widely consumed for their health benefits, such as lowering cholesterol and reducing the risk of cardiovascular diseases. Therefore, better describing the relationship between phytoestrogens and ovarian cancer risk will help adjust health behaviors and cancer prevention. ### Research Objective - **Evaluate the association between dietary phytoestrogen intake and ovarian cancer risk**: Investigate whether dietary phytoestrogen intake is associated with the risk of developing ovarian cancer by analyzing data from the PLCO Cancer Screening Trial. ### Main Findings - **Total Phytoestrogen Intake**: In the Diet History Questionnaire (DHQ) group, the highest quartile of total phytoestrogen intake was significantly associated with a lower risk of ovarian cancer (HR Q4vsQ1 = 0.69, 95% CI: 0.50 - 0.95; P trend = 0.066). - **Isoflavone Intake**: In the DHQ group, the highest quartile of isoflavone intake was significantly associated with a lower risk of ovarian cancer (HR Q4vsQ1 = 0.68, 95% CI: 0.50 - 0.94; P trend = 0.032). - **Other Subtypes**: No significant association was observed between sitosterol intake and ovarian cancer risk. ### Conclusion - **Increasing dietary phytoestrogen intake, especially isoflavones, may reduce the risk of ovarian cancer**. However, more research is needed to validate these findings and explore potential mechanisms.